Cargando…
Shikonin derivatives cause apoptosis and cell cycle arrest in human chondrosarcoma cells via death receptors and MAPK regulation
BACKGROUND: Although chondrosarcoma is the second most common primary malignant bone tumor, treatment options are limited due to its extensive resistance to a chemo- and radiation therapy. Since shikonin has shown potent anticancer activity in various types of cancer cells, it represents a promising...
Autores principales: | Lohberger, Birgit, Glänzer, Dietmar, Kaltenegger, Heike, Eck, Nicole, Leithner, Andreas, Bauer, Rudolf, Kretschmer, Nadine, Steinecker-Frohnwieser, Bibiane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9275282/ https://www.ncbi.nlm.nih.gov/pubmed/35820864 http://dx.doi.org/10.1186/s12885-022-09857-x |
Ejemplares similares
-
Shikonin Derivatives Inhibit Inflammation Processes and Modulate MAPK Signaling in Human Healthy and Osteoarthritis Chondrocytes
por: Lohberger, Birgit, et al.
Publicado: (2022) -
The Biological Assessment of Shikonin and β,β-dimethylacrylshikonin Using a Cellular Myxofibrosarcoma Tumor Heterogeneity Model
por: Lohberger, Birgit, et al.
Publicado: (2023) -
The Proteasome Inhibitor Bortezomib Affects Chondrosarcoma Cells via the Mitochondria-Caspase Dependent Pathway and Enhances Death Receptor Expression and Autophagy
por: Lohberger, Birgit, et al.
Publicado: (2016) -
Diacerein retards cell growth of chondrosarcoma cells at the G2/M cell cycle checkpoint via cyclin B1/CDK1 and CDK2 downregulation
por: Lohberger, Birgit, et al.
Publicado: (2015) -
Effects of a combined therapy of bortezomib and ionizing radiation on chondrosarcoma three-dimensional spheroid cultures
por: Lohberger, Birgit, et al.
Publicado: (2021)